| Autor: |
Kler S; Geza Ad Ltd, Givatayim 53251, Israel. slavakler1@gmail.com., Zalk R; Ilse Katz Institute for Nanoscale Science & Technology, Ben-Gurion University of the Negev, Beer Sheva, 84105, Israel. ranz@post.bgu.ac.il., Upcher A; Ilse Katz Institute for Nanoscale Science & Technology, Ben-Gurion University of the Negev, Beer Sheva, 84105, Israel. ranz@post.bgu.ac.il., Kopatz I; Geza Ad Ltd, Givatayim 53251, Israel. slavakler1@gmail.com. |
| Abstrakt: |
We report a new type of nanoparticle, consisting of a nucleic acid core (>7500 nt) folded into a 35 nm DNA origami sphere, encapsulated by a capsid composed of all three SV40 virus capsid proteins. Compared to the prototype reported previously, whose capsid consists of VP1 only, the new nanoparticle closely adopts the unique intracellular pathway of the native SV40, suggesting that the proteins of the synthetic capsid retain their native viral functionality. Some of the challenges in the design of such near-future composite drugs destined for gene delivery are discussed. |
